Press Releases

Cohen Veterans Bioscience today announced results of a Harris Poll survey of over 2000 respondents revealing that nearly 9 in 10 Americans (88%) agree that post-traumatic stress disorder (PTSD) is a significant problem among U.S. military veterans.

Wounded Warrior Project® (WWP) is working with Cohen Veterans Bioscience (CVB) to identify and study biomarkers that could improve treatment options. For veterans, a specific biomarker found in a blood sample can confirm a PTSD diagnosis and the potential to respond to treatment.

Cohen Veterans Bioscience partners with Early Signal Foundation to advance the use of wearable and home sensors for real-time monitoring of patients and MyHealios for the delivery of Telehealth Mental Wellness Services.

Cohen Veterans Bioscience today announced its partnership with the Open Commons Consortium (OCC) and the University of Chicago to establish the Brain Commons – a one-of-a-kind cloud-hosted platform for unleashing Big Data that will be critical for the understanding of brain conditions.

Wounded Warrior Project® (WWP) and Cohen Veterans Bioscience (CVB) announced a shared initiative to better diagnose and treat PTSD and TBI. The collaboration, known as Research Alliance for PTSD/TBI Innovation and Discovery Diagnostics (RAPID-Dx), is a public-private partnership led by CVB with WWP supporting biomarker research.

WHO WE ARE

Cohen Veterans Bioscience is a national, nonpartisan research 501(c)(3) organization dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders. Learn More